These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 30569110

  • 1. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Fujita S.
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [Abstract] [Full Text] [Related]

  • 2. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Terada K, Itadani M, Okada N, Hassan NMM, Nagatsuka H, Ikeda T, Nohno T, Fujita S.
    Oncol Res; 2018 Jan 19; 26(1):45-58. PubMed ID: 28470144
    [Abstract] [Full Text] [Related]

  • 3. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R, Xu R, Wang Y, Wang W, Jiang L, Gong S.
    Comput Math Methods Med; 2022 Jan 19; 2022():6881932. PubMed ID: 35116073
    [Abstract] [Full Text] [Related]

  • 4. PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.
    Sambandam V, Frederick MJ, Shen L, Tong P, Rao X, Peng S, Singh R, Mazumdar T, Huang C, Li Q, Pickering CR, Myers JN, Wang J, Johnson FM.
    Clin Cancer Res; 2019 Jun 01; 25(11):3329-3340. PubMed ID: 30770351
    [Abstract] [Full Text] [Related]

  • 5. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers.
    Katase N, Nagano K, Fujita S.
    J Oral Biosci; 2020 Mar 01; 62(1):9-15. PubMed ID: 32032750
    [Abstract] [Full Text] [Related]

  • 6. Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.
    Chou MH, Chuang HC, Lin YT, Tsai MH, Kao YH, Lin IC, Huang TL, Fang FM, Chien CY.
    Int J Mol Sci; 2021 Mar 17; 22(6):. PubMed ID: 33802643
    [Abstract] [Full Text] [Related]

  • 7. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL, Liu W, Zhao T, Jin J.
    Med Oncol; 2024 May 23; 41(6):163. PubMed ID: 38777998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
    Li T, Qin Y, Zhen Z, Shen H, Cong T, Schiferle E, Xiao S.
    Cell Prolif; 2019 Sep 23; 52(5):e12651. PubMed ID: 31297902
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway.
    Hu J, Li G, Liu Z, Ma H, Yuan W, Lu Z, Zhang D, Ling H, Zhang F, Liu Y, Liu C, Qiu Y.
    Mol Carcinog; 2023 May 23; 62(5):628-640. PubMed ID: 36727616
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
    Ruicci KM, Pinto N, Khan MI, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Nichols AC.
    Oral Oncol; 2018 Sep 23; 84():95-103. PubMed ID: 30115483
    [Abstract] [Full Text] [Related]

  • 14. Silencing novel long non-coding RNA FKBP9P1 represses malignant progression and inhibits PI3K/AKT signaling of head and neck squamous cell carcinoma in vitro.
    Yang YF, Feng L, Shi Q, Ma HZ, He SZ, Hou LZ, Wang R, Fang JG.
    Chin Med J (Engl); 2020 Sep 05; 133(17):2037-2043. PubMed ID: 32769488
    [Abstract] [Full Text] [Related]

  • 15. The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma.
    Hu Y, Liu M, Xu S, Li S, Yang M, Su T, Yuan Z, Peng H.
    Med Sci Monit; 2020 Nov 26; 26():e927368. PubMed ID: 33281184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM, Yao YL, Liu W, Shen XM, Shi LJ, Wu L.
    Cancer Biomark; 2020 Nov 26; 29(1):51-67. PubMed ID: 32568182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
    Wang J, Shang Y, Wang Y, Li Y, Wang L, Huang S, Lyu X.
    Histol Histopathol; 2024 May 26; 39(5):647-657. PubMed ID: 37971211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.